Malaria: eMedicine Infectious Diseases

Links shared publicly online about this topic.

  • 1,219
    total visits

Malaria: eMedicine Infectious Diseases

emedicine.medscape.com

Overview: Malaria, which predominantly occurs in tropical areas, is a potentially life-threatening disease caused by infection with Plasmodium protozoa transmitted by an infective female Anopheles mosquito vector. Individuals with malaria may present with fever and a wide ...

View full resource at emedicine.medscape.com

Tags: Infectious Disease, Infection, Fever, Protozoan Parasite, Malaria, Disease and Condition, Women's Health, Pregnancy

  • Share

Most Recently Shared on April 23, 2010 at 8:44 pm By:

MedscapeID Medscape HIV & ID

Mefloquine carries higher risk of adverse events in pregnant women with malaria. See the eMedicine topic Malaria. http://bit.ly/cIdjPB

2 years ago...

Infectious Disease News - Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infants |3987249

mdlinx.com — “Infectious Disease Medical Article: Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size in Nigerian infantsView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 1:38 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Maternal malaria status and metabolic profiles in pregnancy and in cord blood: relationships with birth size... http://t.co/ujW9tKtK #ID

3 weeks ago...

Funding cuts put 3.4 mln TB patients at risk: NGOs - Yahoo! News

news.yahoo.com — “From Yahoo! News: LONDON (Reuters) - A $1.7 billion funding shortfall to fight tuberculosis (TB) over the next five years means 3.4 million patients will go untreated and gains made against the disease will be reversed, three non-governmental (NGO) agencies said on Friday. The Global Fund to fight AIDS, TB and Malaria, which has helped prevent 4.1 million deaths from TB, no longer has the resources to expand its work against the infectious disease, the International HIV/AIDS Alliance, the Stop AView full resource at news.yahoo.com

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 7:26 am By:

HealthTrendster HealthTrendster Health Executive

Funding cuts put 3.4 mln TB patients at risk: NGOs - LONDON (Reuters) - A $1.7 billion funding shortfall to fight tu... http://t.co/i6LYl4Nz

3 weeks ago...

Infectious Disease News - The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control trial |3985030

mdlinx.com — “Infectious Disease Medical Article: The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants reduced all-cause mortality in the district of Kolokani, Mali: results from a cluster randomized control trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 21, 2012 at 6:46 am By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

The implementation of malaria intermittent preventive treatment with sulphadoxine-pyrimethamine in infants r... http://t.co/jVk6ZxFE #ID

4 weeks ago...

Infectious Disease News - Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria |3984256

mdlinx.com — “Infectious Disease Medical Article: Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated MalariaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 2:17 pm By:

MDLinx Sandeep Pulim MD Health Communicator, Physician, and Doctor

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Unc... http://t.co/JKTJ0I8M #ID

4 weeks ago...

Infectious Disease News - B-cell activity in children with malaria |3976121

mdlinx.com — “Infectious Disease Medical Article: B-cell activity in children with malariaView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 3:39 am By:

Malaria's Global Death Toll Much Higher Than Thought - MSN Health - Infectious Diseases

health.msn.com — “Study estimates 1.2 million die each year nearly double previous estimatesView full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on February 3, 2012 at 2:45 pm By:

msnhealthnews msn Health News

Malaria's Global Death Toll Much Higher Than Thought: http://t.co/yzixbkAK

2 months ago...

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study : The Lancet Infectious Diseases

thelancet.com — “Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study. By - Dr R McGready MBBS, SJ Lee PhD, J Wiladphaingern, EA Ashl...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on December 13, 2011 at 2:38 pm By:

TheLancet The Lancet Medical Journal

Study finds malaria in early pregnancy trebles risk of miscarriage but treatment with antimalarial drugs appears safe http://t.co/f7UC5rGE

4 months ago...

Annual European CDC report says infectious diseases, drug resistance are concerns

news-medical.net — “"Europe's health is suffering, with around 80,000 cases of tuberculosis infection a year and serious problems with measles, HIV and threats from 'superbug' infections, an annual health report" from the European Centre for Disease Prevention and Control (ECDC) said Thursday, Reuters reports.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 11, 2011 at 5:11 pm By:

West_Nile_Virus News-Medical.Net Health News

West Nile Virus: Annual European CDC report says infectious diseases, drug resistance are concerns: "Europe's he... http://t.co/2b6moIlz

5 months ago...

HIV/AIDS and Other Infectious Diseases | ONE

one.org — “Approximately 11,000 people die every day from HIV/AIDS, tuberculosis and malaria. Nearly two-thirds of these people are living in sub-Saharan Africa. View full resource at one.org

  • View Related
  • Share

Most Recently Shared on November 1, 2011 at 4:00 pm By:

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines

news-medical.net — “Inovio Pharmaceuticals, Inc., which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 Promising Therapeutic Vaccines.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 31, 2011 at 10:20 am By:

NewsMedical News-Medical.Net Health News

Fierce Vaccines highlights Inovio's VGX-3100 as one of 10 Promising Therapeutic Vaccines: Inovio Pharmaceuticals... http://t.co/ray5PTSm

6 months ago...

First malaria vaccine works in major trial - Health - Infectious diseases - msnbc.com

msnbc.msn.com — “An experimental vaccine from GlaxoSmithKline halved the risk of African children getting malaria in a major clinical trial, making it likely to become the world's first shot against the deadly disease. View full resource at msnbc.msn.com

  • View Related
  • Share

Most Recently Shared on October 18, 2011 at 6:08 pm By:

ShelleyWebbRN Shelley Webb Eldercare Expert, Active Health Library, and Nurse

First malaria vaccine works in major trial - Infectious diseases http://t.co/NopJcIbV via @todayshow

6 months ago...

Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today

medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could bView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 4:47 pm By:

medpagetoday MedPage Today Health News

Bright Spot Seen in Failed Malaria Vaccine Trial: http://t.co/lcOg6zcK

7 months ago...

Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today

medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could bView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 3:38 pm By:

PattyGrace Patricia Grace Eldercare Expert

Bright Spot Seen in Failed Malaria Vaccine Trial (CME/CE): (MedPage Today) -- A blood-stage malaria vaccine base... http://t.co/xLAGjAED

7 months ago...

Medical News: Bright Spot Seen in Failed Malaria Vaccine Trial - in Infectious Disease, Vaccines from MedPage Today

medpagetoday.com — “A blood-stage malaria vaccine based on a Plasmodium falciparum antigen failed to prevent clinical infection in a randomized trial, but the investigators held out hope that the product could bView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2011 at 3:16 pm By:

MedicalNews Medical News Health News

Bright Spot Seen in Failed Malaria Vaccine Trial (CME/CE) http://t.co/tJQIigSe

7 months ago...

Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study

news-medical.net — “Inovio Pharmaceuticals, Inc., a leader in the development of synthetic immunogens against cancers and infectious diseases, announced today that it has achieved best-in-class immune responses in a Phase I clinical study of PENNVAX-B, its product for the prevention of the HIV sub-type prevalent in the US and Europe.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 14, 2011 at 9:54 am By:

HIVAIDS_News News-Medical.Net Health News

HIV/AIDS News: Inovio achieves best-in-class immune responses in PENNVAX-B HIV vaccine Phase I study: Inovio Pha... http://t.co/pxBkYpM

7 months ago...

Advertisement